Restrictive versus goal-directed fluid replacement strategy in ovarian cancer cytoreductive surgery (RiGoROCS): A randomised controlled trial.

导出 OA

翻译打印收藏纠错

作者： Jyotsna,Goswami ^[1] ; Angshuman Rudra,Pal ^[1] ; Suparna Mitra,Barman ^[1] ; Anshuman,Sarkar ^[1] ; Viplab,Patro ^[1] ; Jaydip,Bhowmik ^[2] ; Asima,Mukhopadhyay ^[3]

作者单位： Department of Onco-Anesthesia, Tata Medical Center, 14 Major Arterial Road, Newtown, Kolkata, West Bengal, India. ^[1] Department of Gynecological Oncology, Tata Medical Center, 14 Major Arterial Road, Newtown, Kolkata, West Bengal, India. ^[2] Director, Kolkata Gynecological Oncology Trials and Translational Research Group, DD 92, Street No 271, Newtown AA-1, Kolkata, West Bengal, India. ^[3]

关键词 Cost cytoreductive surgery goal-directed fluid therapy length of stay ovarian cancer post-operative morbidity post-operative outcome quality of life

DOI 10.4103/ija.ija_489_23

PMID 38343671

发布时间 2024-02-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交